nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—CYP2C19—Gefitinib—lung cancer	0.0601	0.123	CbGbCtD
Sitaxentan—CYP2C19—Teniposide—lung cancer	0.0582	0.119	CbGbCtD
Sitaxentan—CYP2C9—Gefitinib—lung cancer	0.0499	0.102	CbGbCtD
Sitaxentan—CYP2C9—Teniposide—lung cancer	0.0484	0.099	CbGbCtD
Sitaxentan—CYP3A4—Topotecan—lung cancer	0.0317	0.0649	CbGbCtD
Sitaxentan—CYP3A4—Gefitinib—lung cancer	0.029	0.0594	CbGbCtD
Sitaxentan—CYP3A4—Teniposide—lung cancer	0.0282	0.0576	CbGbCtD
Sitaxentan—CYP2C9—Paclitaxel—lung cancer	0.027	0.0553	CbGbCtD
Sitaxentan—CYP3A4—Vinorelbine—lung cancer	0.0224	0.0457	CbGbCtD
Sitaxentan—CYP2C9—Cisplatin—lung cancer	0.0217	0.0445	CbGbCtD
Sitaxentan—CYP3A4—Crizotinib—lung cancer	0.0178	0.0364	CbGbCtD
Sitaxentan—CYP3A4—Erlotinib—lung cancer	0.0172	0.0351	CbGbCtD
Sitaxentan—CYP3A4—Paclitaxel—lung cancer	0.0157	0.0321	CbGbCtD
Sitaxentan—CYP3A4—Irinotecan—lung cancer	0.0155	0.0317	CbGbCtD
Sitaxentan—CYP3A4—Vinblastine—lung cancer	0.0138	0.0282	CbGbCtD
Sitaxentan—CYP3A4—Etoposide—lung cancer	0.0124	0.0254	CbGbCtD
Sitaxentan—CYP3A4—Docetaxel—lung cancer	0.0114	0.0232	CbGbCtD
Sitaxentan—CYP3A4—Doxorubicin—lung cancer	0.00847	0.0173	CbGbCtD
Sitaxentan—EDNRB—mammary gland—lung cancer	0.00622	0.184	CbGeAlD
Sitaxentan—EDNRA—mammary gland—lung cancer	0.00514	0.152	CbGeAlD
Sitaxentan—EDNRB—bronchus—lung cancer	0.00341	0.101	CbGeAlD
Sitaxentan—EDNRB—cardiac atrium—lung cancer	0.00288	0.085	CbGeAlD
Sitaxentan—EDNRA—bronchus—lung cancer	0.00282	0.0833	CbGeAlD
Sitaxentan—EDNRA—trachea—lung cancer	0.00253	0.0748	CbGeAlD
Sitaxentan—EDNRA—cardiac atrium—lung cancer	0.00238	0.0703	CbGeAlD
Sitaxentan—EDNRB—lung—lung cancer	0.0022	0.065	CbGeAlD
Sitaxentan—EDNRA—lung—lung cancer	0.00182	0.0537	CbGeAlD
Sitaxentan—CYP2C9—mammary gland—lung cancer	0.0017	0.0502	CbGeAlD
Sitaxentan—EDNRB—lymph node—lung cancer	0.0015	0.0445	CbGeAlD
Sitaxentan—EDNRA—lymph node—lung cancer	0.00124	0.0368	CbGeAlD
Sitaxentan—Body temperature increased—Irinotecan—lung cancer	9.05e-05	0.000268	CcSEcCtD
Sitaxentan—Aspartate aminotransferase increased—Doxorubicin—lung cancer	9.05e-05	0.000268	CcSEcCtD
Sitaxentan—Decreased appetite—Cisplatin—lung cancer	9.04e-05	0.000268	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Cisplatin—lung cancer	8.97e-05	0.000266	CcSEcCtD
Sitaxentan—Anaemia—Docetaxel—lung cancer	8.96e-05	0.000266	CcSEcCtD
Sitaxentan—Infestation NOS—Methotrexate—lung cancer	8.94e-05	0.000265	CcSEcCtD
Sitaxentan—Infestation—Methotrexate—lung cancer	8.94e-05	0.000265	CcSEcCtD
Sitaxentan—Anorexia—Paclitaxel—lung cancer	8.9e-05	0.000264	CcSEcCtD
Sitaxentan—Hypotension—Etoposide—lung cancer	8.9e-05	0.000264	CcSEcCtD
Sitaxentan—Pain—Cisplatin—lung cancer	8.89e-05	0.000264	CcSEcCtD
Sitaxentan—Muscular weakness—Doxorubicin—lung cancer	8.86e-05	0.000263	CcSEcCtD
Sitaxentan—Alanine aminotransferase increased—Doxorubicin—lung cancer	8.86e-05	0.000263	CcSEcCtD
Sitaxentan—Vomiting—Vinorelbine—lung cancer	8.83e-05	0.000262	CcSEcCtD
Sitaxentan—Body temperature increased—Gemcitabine—lung cancer	8.82e-05	0.000262	CcSEcCtD
Sitaxentan—Renal failure—Methotrexate—lung cancer	8.79e-05	0.000261	CcSEcCtD
Sitaxentan—Rash—Vinorelbine—lung cancer	8.75e-05	0.00026	CcSEcCtD
Sitaxentan—Dermatitis—Vinorelbine—lung cancer	8.74e-05	0.000259	CcSEcCtD
Sitaxentan—Hypotension—Paclitaxel—lung cancer	8.72e-05	0.000259	CcSEcCtD
Sitaxentan—Stomatitis—Methotrexate—lung cancer	8.72e-05	0.000259	CcSEcCtD
Sitaxentan—Headache—Vinorelbine—lung cancer	8.7e-05	0.000258	CcSEcCtD
Sitaxentan—Conjunctivitis—Methotrexate—lung cancer	8.69e-05	0.000258	CcSEcCtD
Sitaxentan—Asthma—Doxorubicin—lung cancer	8.69e-05	0.000258	CcSEcCtD
Sitaxentan—Leukopenia—Docetaxel—lung cancer	8.68e-05	0.000257	CcSEcCtD
Sitaxentan—Eosinophilia—Doxorubicin—lung cancer	8.6e-05	0.000255	CcSEcCtD
Sitaxentan—Feeling abnormal—Cisplatin—lung cancer	8.57e-05	0.000254	CcSEcCtD
Sitaxentan—Haematuria—Methotrexate—lung cancer	8.53e-05	0.000253	CcSEcCtD
Sitaxentan—Somnolence—Etoposide—lung cancer	8.47e-05	0.000251	CcSEcCtD
Sitaxentan—Angina pectoris—Doxorubicin—lung cancer	8.46e-05	0.000251	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Methotrexate—lung cancer	8.46e-05	0.000251	CcSEcCtD
Sitaxentan—Insomnia—Paclitaxel—lung cancer	8.45e-05	0.000251	CcSEcCtD
Sitaxentan—Epistaxis—Methotrexate—lung cancer	8.44e-05	0.00025	CcSEcCtD
Sitaxentan—Hypersensitivity—Irinotecan—lung cancer	8.43e-05	0.00025	CcSEcCtD
Sitaxentan—Bronchitis—Doxorubicin—lung cancer	8.35e-05	0.000248	CcSEcCtD
Sitaxentan—Somnolence—Paclitaxel—lung cancer	8.3e-05	0.000246	CcSEcCtD
Sitaxentan—Decreased appetite—Etoposide—lung cancer	8.28e-05	0.000246	CcSEcCtD
Sitaxentan—Chest pain—Docetaxel—lung cancer	8.26e-05	0.000245	CcSEcCtD
Sitaxentan—Pancytopenia—Doxorubicin—lung cancer	8.25e-05	0.000245	CcSEcCtD
Sitaxentan—Nausea—Vinorelbine—lung cancer	8.25e-05	0.000245	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Etoposide—lung cancer	8.22e-05	0.000244	CcSEcCtD
Sitaxentan—Dyspepsia—Paclitaxel—lung cancer	8.22e-05	0.000244	CcSEcCtD
Sitaxentan—Body temperature increased—Cisplatin—lung cancer	8.22e-05	0.000244	CcSEcCtD
Sitaxentan—Asthenia—Irinotecan—lung cancer	8.21e-05	0.000244	CcSEcCtD
Sitaxentan—Fatigue—Etoposide—lung cancer	8.21e-05	0.000244	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	8.2e-05	0.000243	CcSEcCtD
Sitaxentan—Pain—Etoposide—lung cancer	8.14e-05	0.000242	CcSEcCtD
Sitaxentan—Constipation—Etoposide—lung cancer	8.14e-05	0.000242	CcSEcCtD
Sitaxentan—Dysuria—Doxorubicin—lung cancer	8.12e-05	0.000241	CcSEcCtD
Sitaxentan—Decreased appetite—Paclitaxel—lung cancer	8.12e-05	0.000241	CcSEcCtD
Sitaxentan—Dry mouth—Docetaxel—lung cancer	8.07e-05	0.00024	CcSEcCtD
Sitaxentan—Haemoglobin—Methotrexate—lung cancer	8.07e-05	0.000239	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Paclitaxel—lung cancer	8.06e-05	0.000239	CcSEcCtD
Sitaxentan—Fatigue—Paclitaxel—lung cancer	8.05e-05	0.000239	CcSEcCtD
Sitaxentan—Hepatitis—Methotrexate—lung cancer	8.03e-05	0.000238	CcSEcCtD
Sitaxentan—Haemorrhage—Methotrexate—lung cancer	8.03e-05	0.000238	CcSEcCtD
Sitaxentan—Pollakiuria—Doxorubicin—lung cancer	8.02e-05	0.000238	CcSEcCtD
Sitaxentan—Asthenia—Gemcitabine—lung cancer	8e-05	0.000237	CcSEcCtD
Sitaxentan—Constipation—Paclitaxel—lung cancer	7.98e-05	0.000237	CcSEcCtD
Sitaxentan—Pain—Paclitaxel—lung cancer	7.98e-05	0.000237	CcSEcCtD
Sitaxentan—Confusional state—Docetaxel—lung cancer	7.98e-05	0.000237	CcSEcCtD
Sitaxentan—Urinary tract disorder—Methotrexate—lung cancer	7.93e-05	0.000235	CcSEcCtD
Sitaxentan—Photosensitivity reaction—Doxorubicin—lung cancer	7.93e-05	0.000235	CcSEcCtD
Sitaxentan—Oedema—Docetaxel—lung cancer	7.91e-05	0.000235	CcSEcCtD
Sitaxentan—Urethral disorder—Methotrexate—lung cancer	7.87e-05	0.000233	CcSEcCtD
Sitaxentan—Infection—Docetaxel—lung cancer	7.86e-05	0.000233	CcSEcCtD
Sitaxentan—Weight decreased—Doxorubicin—lung cancer	7.86e-05	0.000233	CcSEcCtD
Sitaxentan—Feeling abnormal—Etoposide—lung cancer	7.85e-05	0.000233	CcSEcCtD
Sitaxentan—Hyperglycaemia—Doxorubicin—lung cancer	7.84e-05	0.000232	CcSEcCtD
Sitaxentan—Diarrhoea—Irinotecan—lung cancer	7.83e-05	0.000232	CcSEcCtD
Sitaxentan—Nervous system disorder—Docetaxel—lung cancer	7.76e-05	0.00023	CcSEcCtD
Sitaxentan—Thrombocytopenia—Docetaxel—lung cancer	7.75e-05	0.00023	CcSEcCtD
Sitaxentan—Infestation—Doxorubicin—lung cancer	7.74e-05	0.00023	CcSEcCtD
Sitaxentan—Infestation NOS—Doxorubicin—lung cancer	7.74e-05	0.00023	CcSEcCtD
Sitaxentan—Visual impairment—Methotrexate—lung cancer	7.74e-05	0.00023	CcSEcCtD
Sitaxentan—Tachycardia—Docetaxel—lung cancer	7.72e-05	0.000229	CcSEcCtD
Sitaxentan—Feeling abnormal—Paclitaxel—lung cancer	7.69e-05	0.000228	CcSEcCtD
Sitaxentan—Skin disorder—Docetaxel—lung cancer	7.69e-05	0.000228	CcSEcCtD
Sitaxentan—Hypersensitivity—Cisplatin—lung cancer	7.66e-05	0.000227	CcSEcCtD
Sitaxentan—Diarrhoea—Gemcitabine—lung cancer	7.63e-05	0.000226	CcSEcCtD
Sitaxentan—Renal failure—Doxorubicin—lung cancer	7.61e-05	0.000226	CcSEcCtD
Sitaxentan—Dizziness—Irinotecan—lung cancer	7.57e-05	0.000225	CcSEcCtD
Sitaxentan—Urticaria—Etoposide—lung cancer	7.57e-05	0.000224	CcSEcCtD
Sitaxentan—Stomatitis—Doxorubicin—lung cancer	7.55e-05	0.000224	CcSEcCtD
Sitaxentan—Jaundice—Doxorubicin—lung cancer	7.55e-05	0.000224	CcSEcCtD
Sitaxentan—Anorexia—Docetaxel—lung cancer	7.54e-05	0.000224	CcSEcCtD
Sitaxentan—Body temperature increased—Etoposide—lung cancer	7.53e-05	0.000223	CcSEcCtD
Sitaxentan—Conjunctivitis—Doxorubicin—lung cancer	7.53e-05	0.000223	CcSEcCtD
Sitaxentan—Eye disorder—Methotrexate—lung cancer	7.5e-05	0.000223	CcSEcCtD
Sitaxentan—Tinnitus—Methotrexate—lung cancer	7.49e-05	0.000222	CcSEcCtD
Sitaxentan—Asthenia—Cisplatin—lung cancer	7.46e-05	0.000221	CcSEcCtD
Sitaxentan—Cardiac disorder—Methotrexate—lung cancer	7.45e-05	0.000221	CcSEcCtD
Sitaxentan—Urticaria—Paclitaxel—lung cancer	7.42e-05	0.00022	CcSEcCtD
Sitaxentan—Hypotension—Docetaxel—lung cancer	7.4e-05	0.000219	CcSEcCtD
Sitaxentan—Haematuria—Doxorubicin—lung cancer	7.38e-05	0.000219	CcSEcCtD
Sitaxentan—Body temperature increased—Paclitaxel—lung cancer	7.38e-05	0.000219	CcSEcCtD
Sitaxentan—Hepatobiliary disease—Doxorubicin—lung cancer	7.32e-05	0.000217	CcSEcCtD
Sitaxentan—Epistaxis—Doxorubicin—lung cancer	7.3e-05	0.000217	CcSEcCtD
Sitaxentan—Angiopathy—Methotrexate—lung cancer	7.28e-05	0.000216	CcSEcCtD
Sitaxentan—Vomiting—Irinotecan—lung cancer	7.28e-05	0.000216	CcSEcCtD
Sitaxentan—Sinusitis—Doxorubicin—lung cancer	7.27e-05	0.000216	CcSEcCtD
Sitaxentan—Immune system disorder—Methotrexate—lung cancer	7.25e-05	0.000215	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methotrexate—lung cancer	7.24e-05	0.000215	CcSEcCtD
Sitaxentan—Rash—Irinotecan—lung cancer	7.22e-05	0.000214	CcSEcCtD
Sitaxentan—Dermatitis—Irinotecan—lung cancer	7.21e-05	0.000214	CcSEcCtD
Sitaxentan—Headache—Irinotecan—lung cancer	7.17e-05	0.000213	CcSEcCtD
Sitaxentan—Insomnia—Docetaxel—lung cancer	7.16e-05	0.000212	CcSEcCtD
Sitaxentan—Diarrhoea—Cisplatin—lung cancer	7.11e-05	0.000211	CcSEcCtD
Sitaxentan—Alopecia—Methotrexate—lung cancer	7.09e-05	0.00021	CcSEcCtD
Sitaxentan—Vomiting—Gemcitabine—lung cancer	7.09e-05	0.00021	CcSEcCtD
Sitaxentan—Bradycardia—Doxorubicin—lung cancer	7.08e-05	0.00021	CcSEcCtD
Sitaxentan—Somnolence—Docetaxel—lung cancer	7.04e-05	0.000209	CcSEcCtD
Sitaxentan—Mental disorder—Methotrexate—lung cancer	7.03e-05	0.000209	CcSEcCtD
Sitaxentan—Rash—Gemcitabine—lung cancer	7.03e-05	0.000209	CcSEcCtD
Sitaxentan—Dermatitis—Gemcitabine—lung cancer	7.03e-05	0.000208	CcSEcCtD
Sitaxentan—Hypersensitivity—Etoposide—lung cancer	7.02e-05	0.000208	CcSEcCtD
Sitaxentan—Malnutrition—Methotrexate—lung cancer	6.99e-05	0.000207	CcSEcCtD
Sitaxentan—Haemoglobin—Doxorubicin—lung cancer	6.99e-05	0.000207	CcSEcCtD
Sitaxentan—Headache—Gemcitabine—lung cancer	6.99e-05	0.000207	CcSEcCtD
Sitaxentan—Rhinitis—Doxorubicin—lung cancer	6.97e-05	0.000207	CcSEcCtD
Sitaxentan—Dyspepsia—Docetaxel—lung cancer	6.97e-05	0.000207	CcSEcCtD
Sitaxentan—Hepatitis—Doxorubicin—lung cancer	6.95e-05	0.000206	CcSEcCtD
Sitaxentan—Haemorrhage—Doxorubicin—lung cancer	6.95e-05	0.000206	CcSEcCtD
Sitaxentan—Decreased appetite—Docetaxel—lung cancer	6.88e-05	0.000204	CcSEcCtD
Sitaxentan—Hypersensitivity—Paclitaxel—lung cancer	6.88e-05	0.000204	CcSEcCtD
Sitaxentan—Urinary tract disorder—Doxorubicin—lung cancer	6.87e-05	0.000204	CcSEcCtD
Sitaxentan—Oedema peripheral—Doxorubicin—lung cancer	6.85e-05	0.000203	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Docetaxel—lung cancer	6.83e-05	0.000203	CcSEcCtD
Sitaxentan—Asthenia—Etoposide—lung cancer	6.83e-05	0.000203	CcSEcCtD
Sitaxentan—Fatigue—Docetaxel—lung cancer	6.82e-05	0.000202	CcSEcCtD
Sitaxentan—Urethral disorder—Doxorubicin—lung cancer	6.81e-05	0.000202	CcSEcCtD
Sitaxentan—Nausea—Irinotecan—lung cancer	6.8e-05	0.000202	CcSEcCtD
Sitaxentan—Constipation—Docetaxel—lung cancer	6.77e-05	0.000201	CcSEcCtD
Sitaxentan—Pain—Docetaxel—lung cancer	6.77e-05	0.000201	CcSEcCtD
Sitaxentan—Visual impairment—Doxorubicin—lung cancer	6.7e-05	0.000199	CcSEcCtD
Sitaxentan—Asthenia—Paclitaxel—lung cancer	6.7e-05	0.000199	CcSEcCtD
Sitaxentan—Nausea—Gemcitabine—lung cancer	6.62e-05	0.000197	CcSEcCtD
Sitaxentan—Vomiting—Cisplatin—lung cancer	6.61e-05	0.000196	CcSEcCtD
Sitaxentan—Rash—Cisplatin—lung cancer	6.55e-05	0.000194	CcSEcCtD
Sitaxentan—Dermatitis—Cisplatin—lung cancer	6.55e-05	0.000194	CcSEcCtD
Sitaxentan—Feeling abnormal—Docetaxel—lung cancer	6.52e-05	0.000193	CcSEcCtD
Sitaxentan—Diarrhoea—Etoposide—lung cancer	6.52e-05	0.000193	CcSEcCtD
Sitaxentan—Eye disorder—Doxorubicin—lung cancer	6.5e-05	0.000193	CcSEcCtD
Sitaxentan—Ill-defined disorder—Methotrexate—lung cancer	6.48e-05	0.000192	CcSEcCtD
Sitaxentan—Tinnitus—Doxorubicin—lung cancer	6.48e-05	0.000192	CcSEcCtD
Sitaxentan—Anaemia—Methotrexate—lung cancer	6.46e-05	0.000192	CcSEcCtD
Sitaxentan—Cardiac disorder—Doxorubicin—lung cancer	6.45e-05	0.000191	CcSEcCtD
Sitaxentan—Flushing—Doxorubicin—lung cancer	6.45e-05	0.000191	CcSEcCtD
Sitaxentan—Diarrhoea—Paclitaxel—lung cancer	6.39e-05	0.00019	CcSEcCtD
Sitaxentan—Angiopathy—Doxorubicin—lung cancer	6.31e-05	0.000187	CcSEcCtD
Sitaxentan—Malaise—Methotrexate—lung cancer	6.3e-05	0.000187	CcSEcCtD
Sitaxentan—Dizziness—Etoposide—lung cancer	6.3e-05	0.000187	CcSEcCtD
Sitaxentan—Immune system disorder—Doxorubicin—lung cancer	6.28e-05	0.000186	CcSEcCtD
Sitaxentan—Vertigo—Methotrexate—lung cancer	6.28e-05	0.000186	CcSEcCtD
Sitaxentan—Mediastinal disorder—Doxorubicin—lung cancer	6.27e-05	0.000186	CcSEcCtD
Sitaxentan—Body temperature increased—Docetaxel—lung cancer	6.26e-05	0.000186	CcSEcCtD
Sitaxentan—Leukopenia—Methotrexate—lung cancer	6.26e-05	0.000186	CcSEcCtD
Sitaxentan—Dizziness—Paclitaxel—lung cancer	6.17e-05	0.000183	CcSEcCtD
Sitaxentan—Nausea—Cisplatin—lung cancer	6.17e-05	0.000183	CcSEcCtD
Sitaxentan—Alopecia—Doxorubicin—lung cancer	6.14e-05	0.000182	CcSEcCtD
Sitaxentan—Mental disorder—Doxorubicin—lung cancer	6.09e-05	0.000181	CcSEcCtD
Sitaxentan—Vomiting—Etoposide—lung cancer	6.05e-05	0.00018	CcSEcCtD
Sitaxentan—Malnutrition—Doxorubicin—lung cancer	6.05e-05	0.00018	CcSEcCtD
Sitaxentan—Rash—Etoposide—lung cancer	6e-05	0.000178	CcSEcCtD
Sitaxentan—Dermatitis—Etoposide—lung cancer	6e-05	0.000178	CcSEcCtD
Sitaxentan—Headache—Etoposide—lung cancer	5.97e-05	0.000177	CcSEcCtD
Sitaxentan—Chest pain—Methotrexate—lung cancer	5.95e-05	0.000177	CcSEcCtD
Sitaxentan—Tension—Doxorubicin—lung cancer	5.94e-05	0.000176	CcSEcCtD
Sitaxentan—Vomiting—Paclitaxel—lung cancer	5.94e-05	0.000176	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	5.91e-05	0.000175	CcSEcCtD
Sitaxentan—Rash—Paclitaxel—lung cancer	5.89e-05	0.000175	CcSEcCtD
Sitaxentan—Dermatitis—Paclitaxel—lung cancer	5.88e-05	0.000174	CcSEcCtD
Sitaxentan—Discomfort—Methotrexate—lung cancer	5.88e-05	0.000174	CcSEcCtD
Sitaxentan—Nervousness—Doxorubicin—lung cancer	5.88e-05	0.000174	CcSEcCtD
Sitaxentan—Headache—Paclitaxel—lung cancer	5.85e-05	0.000174	CcSEcCtD
Sitaxentan—Hypersensitivity—Docetaxel—lung cancer	5.83e-05	0.000173	CcSEcCtD
Sitaxentan—Muscle spasms—Doxorubicin—lung cancer	5.82e-05	0.000173	CcSEcCtD
Sitaxentan—Confusional state—Methotrexate—lung cancer	5.75e-05	0.000171	CcSEcCtD
Sitaxentan—Asthenia—Docetaxel—lung cancer	5.68e-05	0.000168	CcSEcCtD
Sitaxentan—Infection—Methotrexate—lung cancer	5.67e-05	0.000168	CcSEcCtD
Sitaxentan—Nausea—Etoposide—lung cancer	5.66e-05	0.000168	CcSEcCtD
Sitaxentan—Ill-defined disorder—Doxorubicin—lung cancer	5.62e-05	0.000167	CcSEcCtD
Sitaxentan—Nervous system disorder—Methotrexate—lung cancer	5.59e-05	0.000166	CcSEcCtD
Sitaxentan—Anaemia—Doxorubicin—lung cancer	5.59e-05	0.000166	CcSEcCtD
Sitaxentan—Thrombocytopenia—Methotrexate—lung cancer	5.58e-05	0.000166	CcSEcCtD
Sitaxentan—Agitation—Doxorubicin—lung cancer	5.56e-05	0.000165	CcSEcCtD
Sitaxentan—Nausea—Paclitaxel—lung cancer	5.55e-05	0.000165	CcSEcCtD
Sitaxentan—Skin disorder—Methotrexate—lung cancer	5.54e-05	0.000164	CcSEcCtD
Sitaxentan—Malaise—Doxorubicin—lung cancer	5.46e-05	0.000162	CcSEcCtD
Sitaxentan—Vertigo—Doxorubicin—lung cancer	5.44e-05	0.000161	CcSEcCtD
Sitaxentan—Anorexia—Methotrexate—lung cancer	5.44e-05	0.000161	CcSEcCtD
Sitaxentan—Leukopenia—Doxorubicin—lung cancer	5.42e-05	0.000161	CcSEcCtD
Sitaxentan—Diarrhoea—Docetaxel—lung cancer	5.41e-05	0.000161	CcSEcCtD
Sitaxentan—Hypotension—Methotrexate—lung cancer	5.33e-05	0.000158	CcSEcCtD
Sitaxentan—Dizziness—Docetaxel—lung cancer	5.23e-05	0.000155	CcSEcCtD
Sitaxentan—Insomnia—Methotrexate—lung cancer	5.16e-05	0.000153	CcSEcCtD
Sitaxentan—Chest pain—Doxorubicin—lung cancer	5.15e-05	0.000153	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.12e-05	0.000152	CcSEcCtD
Sitaxentan—Discomfort—Doxorubicin—lung cancer	5.09e-05	0.000151	CcSEcCtD
Sitaxentan—Somnolence—Methotrexate—lung cancer	5.07e-05	0.00015	CcSEcCtD
Sitaxentan—Dry mouth—Doxorubicin—lung cancer	5.04e-05	0.000149	CcSEcCtD
Sitaxentan—Vomiting—Docetaxel—lung cancer	5.03e-05	0.000149	CcSEcCtD
Sitaxentan—Dyspepsia—Methotrexate—lung cancer	5.02e-05	0.000149	CcSEcCtD
Sitaxentan—Rash—Docetaxel—lung cancer	4.99e-05	0.000148	CcSEcCtD
Sitaxentan—Dermatitis—Docetaxel—lung cancer	4.99e-05	0.000148	CcSEcCtD
Sitaxentan—Confusional state—Doxorubicin—lung cancer	4.98e-05	0.000148	CcSEcCtD
Sitaxentan—Decreased appetite—Methotrexate—lung cancer	4.96e-05	0.000147	CcSEcCtD
Sitaxentan—Headache—Docetaxel—lung cancer	4.96e-05	0.000147	CcSEcCtD
Sitaxentan—Oedema—Doxorubicin—lung cancer	4.94e-05	0.000147	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Methotrexate—lung cancer	4.92e-05	0.000146	CcSEcCtD
Sitaxentan—Fatigue—Methotrexate—lung cancer	4.92e-05	0.000146	CcSEcCtD
Sitaxentan—Infection—Doxorubicin—lung cancer	4.91e-05	0.000146	CcSEcCtD
Sitaxentan—Pain—Methotrexate—lung cancer	4.88e-05	0.000145	CcSEcCtD
Sitaxentan—Nervous system disorder—Doxorubicin—lung cancer	4.84e-05	0.000144	CcSEcCtD
Sitaxentan—Thrombocytopenia—Doxorubicin—lung cancer	4.84e-05	0.000143	CcSEcCtD
Sitaxentan—Tachycardia—Doxorubicin—lung cancer	4.82e-05	0.000143	CcSEcCtD
Sitaxentan—Skin disorder—Doxorubicin—lung cancer	4.8e-05	0.000142	CcSEcCtD
Sitaxentan—Anorexia—Doxorubicin—lung cancer	4.71e-05	0.00014	CcSEcCtD
Sitaxentan—Nausea—Docetaxel—lung cancer	4.7e-05	0.000139	CcSEcCtD
Sitaxentan—Feeling abnormal—Methotrexate—lung cancer	4.7e-05	0.000139	CcSEcCtD
Sitaxentan—Hypotension—Doxorubicin—lung cancer	4.62e-05	0.000137	CcSEcCtD
Sitaxentan—Urticaria—Methotrexate—lung cancer	4.53e-05	0.000134	CcSEcCtD
Sitaxentan—Body temperature increased—Methotrexate—lung cancer	4.51e-05	0.000134	CcSEcCtD
Sitaxentan—Insomnia—Doxorubicin—lung cancer	4.47e-05	0.000133	CcSEcCtD
Sitaxentan—Somnolence—Doxorubicin—lung cancer	4.39e-05	0.00013	CcSEcCtD
Sitaxentan—Dyspepsia—Doxorubicin—lung cancer	4.35e-05	0.000129	CcSEcCtD
Sitaxentan—Decreased appetite—Doxorubicin—lung cancer	4.29e-05	0.000127	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Doxorubicin—lung cancer	4.26e-05	0.000126	CcSEcCtD
Sitaxentan—Fatigue—Doxorubicin—lung cancer	4.26e-05	0.000126	CcSEcCtD
Sitaxentan—Constipation—Doxorubicin—lung cancer	4.22e-05	0.000125	CcSEcCtD
Sitaxentan—Pain—Doxorubicin—lung cancer	4.22e-05	0.000125	CcSEcCtD
Sitaxentan—Hypersensitivity—Methotrexate—lung cancer	4.2e-05	0.000125	CcSEcCtD
Sitaxentan—Asthenia—Methotrexate—lung cancer	4.09e-05	0.000121	CcSEcCtD
Sitaxentan—Feeling abnormal—Doxorubicin—lung cancer	4.07e-05	0.000121	CcSEcCtD
Sitaxentan—Urticaria—Doxorubicin—lung cancer	3.92e-05	0.000116	CcSEcCtD
Sitaxentan—Body temperature increased—Doxorubicin—lung cancer	3.9e-05	0.000116	CcSEcCtD
Sitaxentan—Diarrhoea—Methotrexate—lung cancer	3.9e-05	0.000116	CcSEcCtD
Sitaxentan—Dizziness—Methotrexate—lung cancer	3.77e-05	0.000112	CcSEcCtD
Sitaxentan—Hypersensitivity—Doxorubicin—lung cancer	3.64e-05	0.000108	CcSEcCtD
Sitaxentan—Vomiting—Methotrexate—lung cancer	3.63e-05	0.000108	CcSEcCtD
Sitaxentan—Rash—Methotrexate—lung cancer	3.6e-05	0.000107	CcSEcCtD
Sitaxentan—Dermatitis—Methotrexate—lung cancer	3.59e-05	0.000107	CcSEcCtD
Sitaxentan—Headache—Methotrexate—lung cancer	3.57e-05	0.000106	CcSEcCtD
Sitaxentan—Asthenia—Doxorubicin—lung cancer	3.54e-05	0.000105	CcSEcCtD
Sitaxentan—Nausea—Methotrexate—lung cancer	3.39e-05	0.000101	CcSEcCtD
Sitaxentan—Diarrhoea—Doxorubicin—lung cancer	3.38e-05	0.0001	CcSEcCtD
Sitaxentan—Dizziness—Doxorubicin—lung cancer	3.27e-05	9.69e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—KDR—lung cancer	3.22e-05	0.00023	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—ERBB2—lung cancer	3.22e-05	0.00023	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PIK3CB—lung cancer	3.18e-05	0.000227	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MTOR—lung cancer	3.18e-05	0.000227	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PGAM1—lung cancer	3.16e-05	0.000226	CbGpPWpGaD
Sitaxentan—Vomiting—Doxorubicin—lung cancer	3.14e-05	9.32e-05	CcSEcCtD
Sitaxentan—Rash—Doxorubicin—lung cancer	3.11e-05	9.24e-05	CcSEcCtD
Sitaxentan—Dermatitis—Doxorubicin—lung cancer	3.11e-05	9.23e-05	CcSEcCtD
Sitaxentan—Headache—Doxorubicin—lung cancer	3.09e-05	9.18e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CXCL8—lung cancer	3.06e-05	0.000218	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTM2—lung cancer	3.04e-05	0.000217	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CNDP2—lung cancer	3.04e-05	0.000217	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—HRAS—lung cancer	3.04e-05	0.000217	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2A7—lung cancer	3.02e-05	0.000215	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—APC—lung cancer	2.97e-05	0.000212	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—KIT—lung cancer	2.97e-05	0.000212	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3CG—lung cancer	2.97e-05	0.000212	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—NRAS—lung cancer	2.97e-05	0.000212	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—MTMR3—lung cancer	2.96e-05	0.000211	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—AKT1—lung cancer	2.95e-05	0.000211	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—SDC4—lung cancer	2.95e-05	0.000211	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EGF—lung cancer	2.94e-05	0.000209	CbGpPWpGaD
Sitaxentan—Nausea—Doxorubicin—lung cancer	2.93e-05	8.7e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CASP3—lung cancer	2.92e-05	0.000209	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL2—lung cancer	2.92e-05	0.000208	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—lung cancer	2.91e-05	0.000207	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PGAM1—lung cancer	2.88e-05	0.000206	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CCND1—lung cancer	2.85e-05	0.000203	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—MAPK3—lung cancer	2.84e-05	0.000203	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—JUN—lung cancer	2.84e-05	0.000203	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—POMC—lung cancer	2.83e-05	0.000202	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ATP5H—lung cancer	2.81e-05	0.000201	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—POMC—lung cancer	2.8e-05	0.0002	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—BRAF—lung cancer	2.79e-05	0.000199	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP9—lung cancer	2.76e-05	0.000197	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6R—lung cancer	2.76e-05	0.000197	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CDKN1A—lung cancer	2.75e-05	0.000197	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CREBBP—lung cancer	2.75e-05	0.000196	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2A7—lung cancer	2.75e-05	0.000196	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PTEN—lung cancer	2.75e-05	0.000196	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—EGFR—lung cancer	2.71e-05	0.000193	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—SDC4—lung cancer	2.69e-05	0.000192	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTA3—lung cancer	2.69e-05	0.000192	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—RRM1—lung cancer	2.69e-05	0.000192	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—AKT1—lung cancer	2.68e-05	0.000191	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAP2K1—lung cancer	2.63e-05	0.000188	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EP300—lung cancer	2.62e-05	0.000187	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3CD—lung cancer	2.61e-05	0.000186	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—PIK3CA—lung cancer	2.59e-05	0.000185	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—KRAS—lung cancer	2.56e-05	0.000182	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SRC—lung cancer	2.55e-05	0.000182	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—B4GALT5—lung cancer	2.53e-05	0.00018	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLBD1—lung cancer	2.51e-05	0.000179	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—lung cancer	2.48e-05	0.000177	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTA4—lung cancer	2.46e-05	0.000175	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—STAT3—lung cancer	2.46e-05	0.000175	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NRAS—lung cancer	2.45e-05	0.000175	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—RRM1—lung cancer	2.45e-05	0.000175	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTA3—lung cancer	2.45e-05	0.000175	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.4e-05	0.000171	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTA2—lung cancer	2.4e-05	0.000171	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—PIK3CA—lung cancer	2.35e-05	0.000168	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MAPK3—lung cancer	2.35e-05	0.000168	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MDM2—lung cancer	2.34e-05	0.000167	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RAF1—lung cancer	2.33e-05	0.000166	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTA1—lung cancer	2.31e-05	0.000165	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ERBB2—lung cancer	2.31e-05	0.000165	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—B4GALT5—lung cancer	2.3e-05	0.000164	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HSD17B10—lung cancer	2.29e-05	0.000164	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCC3—lung cancer	2.28e-05	0.000163	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MYC—lung cancer	2.28e-05	0.000163	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3CB—lung cancer	2.28e-05	0.000162	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MTOR—lung cancer	2.28e-05	0.000162	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTA4—lung cancer	2.24e-05	0.00016	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EGFR—lung cancer	2.23e-05	0.000159	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AKR1C1—lung cancer	2.21e-05	0.000158	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.19e-05	0.000156	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL8—lung cancer	2.19e-05	0.000156	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTA2—lung cancer	2.18e-05	0.000156	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—HRAS—lung cancer	2.17e-05	0.000155	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—UGT1A1—lung cancer	2.15e-05	0.000153	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CKB—lung cancer	2.13e-05	0.000152	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—AKT1—lung cancer	2.11e-05	0.000151	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—KRAS—lung cancer	2.11e-05	0.000151	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTA1—lung cancer	2.11e-05	0.00015	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CASP3—lung cancer	2.09e-05	0.000149	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2—lung cancer	2.09e-05	0.000149	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCC3—lung cancer	2.08e-05	0.000149	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—lung cancer	2.08e-05	0.000148	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GNG11—lung cancer	2.07e-05	0.000148	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.06e-05	0.000147	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCND1—lung cancer	2.04e-05	0.000145	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—JUN—lung cancer	2.03e-05	0.000145	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AKR1C1—lung cancer	2.02e-05	0.000144	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTM2—lung cancer	2e-05	0.000143	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CNDP2—lung cancer	2e-05	0.000143	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP9—lung cancer	1.98e-05	0.000141	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALDOA—lung cancer	1.97e-05	0.000141	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CDKN1A—lung cancer	1.97e-05	0.000141	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PTEN—lung cancer	1.97e-05	0.00014	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—UGT1A1—lung cancer	1.96e-05	0.00014	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—MTMR3—lung cancer	1.95e-05	0.000139	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PIK3CA—lung cancer	1.94e-05	0.000138	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—AKT1—lung cancer	1.92e-05	0.000137	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NCOA3—lung cancer	1.91e-05	0.000137	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PGAM1—lung cancer	1.9e-05	0.000136	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GNG11—lung cancer	1.89e-05	0.000135	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.88e-05	0.000134	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.88e-05	0.000134	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EP300—lung cancer	1.88e-05	0.000134	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TP53—lung cancer	1.87e-05	0.000134	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCG2—lung cancer	1.86e-05	0.000133	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADCY1—lung cancer	1.86e-05	0.000133	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ENO2—lung cancer	1.83e-05	0.00013	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HPGDS—lung cancer	1.83e-05	0.00013	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SRC—lung cancer	1.82e-05	0.00013	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.82e-05	0.00013	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2A7—lung cancer	1.81e-05	0.000129	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALDOA—lung cancer	1.8e-05	0.000128	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—HRAS—lung cancer	1.79e-05	0.000128	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.79e-05	0.000128	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—lung cancer	1.78e-05	0.000127	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—SDC4—lung cancer	1.77e-05	0.000127	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTT1—lung cancer	1.77e-05	0.000126	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—STAT3—lung cancer	1.76e-05	0.000125	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NRAS—lung cancer	1.75e-05	0.000125	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2A6—lung cancer	1.75e-05	0.000125	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GCLC—lung cancer	1.75e-05	0.000125	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NCOA3—lung cancer	1.75e-05	0.000125	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.74e-05	0.000124	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—lung cancer	1.72e-05	0.000122	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.72e-05	0.000122	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADCY1—lung cancer	1.7e-05	0.000121	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCG2—lung cancer	1.7e-05	0.000121	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MAPK3—lung cancer	1.68e-05	0.00012	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ENO2—lung cancer	1.67e-05	0.000119	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HPGDS—lung cancer	1.67e-05	0.000119	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ENO1—lung cancer	1.66e-05	0.000118	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.66e-05	0.000118	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.65e-05	0.000118	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MYC—lung cancer	1.63e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.63e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.63e-05	0.000117	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—RRM1—lung cancer	1.62e-05	0.000115	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTA3—lung cancer	1.62e-05	0.000115	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTT1—lung cancer	1.62e-05	0.000115	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EGFR—lung cancer	1.6e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2A6—lung cancer	1.6e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GCLC—lung cancer	1.6e-05	0.000114	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.59e-05	0.000114	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—AKT1—lung cancer	1.58e-05	0.000113	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—B4GALT5—lung cancer	1.52e-05	0.000108	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ENO1—lung cancer	1.51e-05	0.000108	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—KRAS—lung cancer	1.51e-05	0.000108	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.51e-05	0.000108	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP2E1—lung cancer	1.49e-05	0.000106	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.49e-05	0.000106	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTA4—lung cancer	1.48e-05	0.000105	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NQO1—lung cancer	1.47e-05	0.000105	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.44e-05	0.000103	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTA2—lung cancer	1.44e-05	0.000103	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.43e-05	0.000102	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTA1—lung cancer	1.39e-05	9.92e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PIK3CA—lung cancer	1.39e-05	9.9e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCC3—lung cancer	1.37e-05	9.81e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP2E1—lung cancer	1.36e-05	9.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NQO1—lung cancer	1.34e-05	9.58e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TP53—lung cancer	1.34e-05	9.58e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AKR1C1—lung cancer	1.33e-05	9.5e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—STK11—lung cancer	1.33e-05	9.47e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.31e-05	9.38e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.3e-05	9.3e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—UGT1A1—lung cancer	1.29e-05	9.22e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—HRAS—lung cancer	1.28e-05	9.16e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.25e-05	8.89e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GNG11—lung cancer	1.25e-05	8.89e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—lung cancer	1.23e-05	8.77e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTP1—lung cancer	1.23e-05	8.76e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—STK11—lung cancer	1.21e-05	8.64e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAT—lung cancer	1.2e-05	8.53e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.19e-05	8.48e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALDOA—lung cancer	1.19e-05	8.46e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ABCB1—lung cancer	1.16e-05	8.3e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NCOA3—lung cancer	1.15e-05	8.22e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—TYMS—lung cancer	1.14e-05	8.15e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.14e-05	8.11e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AKT1—lung cancer	1.13e-05	8.09e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTM1—lung cancer	1.13e-05	8.05e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADCY1—lung cancer	1.12e-05	7.99e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCG2—lung cancer	1.12e-05	7.99e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTP1—lung cancer	1.12e-05	7.99e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HPGDS—lung cancer	1.1e-05	7.84e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ENO2—lung cancer	1.1e-05	7.84e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.09e-05	7.79e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAT—lung cancer	1.09e-05	7.78e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.08e-05	7.73e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CYP1A1—lung cancer	1.07e-05	7.63e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTT1—lung cancer	1.07e-05	7.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ERCC2—lung cancer	1.06e-05	7.57e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ABCB1—lung cancer	1.06e-05	7.56e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2A6—lung cancer	1.05e-05	7.52e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GCLC—lung cancer	1.05e-05	7.52e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—TYMS—lung cancer	1.04e-05	7.43e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTM1—lung cancer	1.03e-05	7.34e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ENO1—lung cancer	9.98e-06	7.12e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CYP1A1—lung cancer	9.75e-06	6.96e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ERCC2—lung cancer	9.67e-06	6.9e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—APOA1—lung cancer	9.18e-06	6.55e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP2E1—lung cancer	8.95e-06	6.39e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NQO1—lung cancer	8.85e-06	6.32e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.79e-06	6.27e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3CG—lung cancer	8.38e-06	5.98e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—APOA1—lung cancer	8.37e-06	5.97e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.01e-06	5.72e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—STK11—lung cancer	7.98e-06	5.7e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—POMC—lung cancer	7.98e-06	5.69e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CREBBP—lung cancer	7.77e-06	5.54e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3CG—lung cancer	7.64e-06	5.45e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTP1—lung cancer	7.38e-06	5.27e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3CD—lung cancer	7.37e-06	5.26e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—POMC—lung cancer	7.27e-06	5.19e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—lung cancer	7.27e-06	5.19e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAT—lung cancer	7.19e-06	5.13e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CREBBP—lung cancer	7.08e-06	5.06e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ABCB1—lung cancer	6.99e-06	4.99e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—TYMS—lung cancer	6.87e-06	4.9e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTM1—lung cancer	6.79e-06	4.84e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3CD—lung cancer	6.72e-06	4.79e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—lung cancer	6.63e-06	4.73e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CYP1A1—lung cancer	6.43e-06	4.59e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3CB—lung cancer	6.42e-06	4.58e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ERCC2—lung cancer	6.38e-06	4.55e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—lung cancer	6.36e-06	4.54e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3CB—lung cancer	5.85e-06	4.18e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—lung cancer	5.8e-06	4.14e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTEN—lung cancer	5.55e-06	3.96e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—APOA1—lung cancer	5.52e-06	3.94e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—EP300—lung cancer	5.29e-06	3.78e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTEN—lung cancer	5.06e-06	3.61e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3CG—lung cancer	5.04e-06	3.6e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—EP300—lung cancer	4.82e-06	3.44e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—POMC—lung cancer	4.8e-06	3.42e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CREBBP—lung cancer	4.67e-06	3.33e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3CD—lung cancer	4.43e-06	3.16e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—lung cancer	4.37e-06	3.12e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PIK3CA—lung cancer	3.91e-06	2.79e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3CB—lung cancer	3.86e-06	2.76e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—lung cancer	3.83e-06	2.73e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PIK3CA—lung cancer	3.57e-06	2.55e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTEN—lung cancer	3.34e-06	2.38e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—AKT1—lung cancer	3.2e-06	2.28e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—EP300—lung cancer	3.18e-06	2.27e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—AKT1—lung cancer	2.92e-06	2.08e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PIK3CA—lung cancer	2.35e-06	1.68e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—AKT1—lung cancer	1.92e-06	1.37e-05	CbGpPWpGaD
